Urology Research & Practice
Original Articles

Scoring System to Personalize Management of Emphysematous Pyelonephritis

1.

Department of Urology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

Urol Res Pract 2024; 50: 193-197
DOI: 10.5152/tud.2024.23165
Read: 216 Downloads: 65 Published: 21 October 2024

Objective: Emphysematous pyelonephritis (EPN) is a life-threatening condition that requires prompt diagnosis and treatment. The prognosis of EPN is variable, and there is no single treatment that is universally effective.

Materials and Methods: In this study, we developed a scoring system to predict the prognosis of EPN and to guide management. The scoring system was developed based on a retrospective analysis of 91 patients with EPN. Nineteen risk factors for emphysematous pyelonephritis were assessed with univariate and multivariate analysis.

Results: Seven factors were found significant on analysis. The scoring system was developed by including these 7 risk factors: renal stone disease, leukocytosis, raised creatinine, EPN grade, and septic shock. The score ranged from 1 to 18, with a higher score indicating a worse prognosis. The scoring system was able to stratify patients into three risk groups: good risk, intermediate risk, and poor risk. The scoring system can be used to personalize the management of EPN. Patients in the good-risk group may be managed with conservative treatment, while patients in the intermediate-risk and poor-risk groups may require intervention, such as DJ stenting, percutaneous nephrolithotomy or nephrectomy. The scoring system is a valuable tool for predicting the prognosis of EPN and guiding management. It can help clinicians to tailor treatment to the individual patient and to improve outcomes.

Conclusion: The prognostic score helps identify patients who are at high risk. This score helps in the selection of appropriate management options.

Cite this article as: Mittal A, Kumar D, Panwar VK, et al. Scoring system to personalize management of emphysematous pyelonephritis. Urol Res Pract. 2024;50(3):193-197.

Files
EISSN 2980-1478